Based on these findings, we hypothesize that VNP20009, as a targeted oncolytic bacterium, and MIIP, as an anti-cancer protein, may synergistically enhance the anti-tumor effect, potentially addressing the current shortcomings of drug therapy. This evidence concerns the gene MIIP and neoplasm.